መነሻ › ማይሎፋይብሮሲስ › Washington › Seattle
በSeattle፣ WA ለማይሎፋይብሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለማይሎፋይብሮሲስ የሚደረጉ 11 ጥናቶች በSeattle እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Washington - Fred Hutchinson Cancer Center, Seattle
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Fred Hutch Cancer Research, Seattle
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Washington, Seattle
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Washington, Seattle
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- GSK Investigational Site, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Seattle
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Fred Hutchinson Cancer Centre, Seattle
በሌሎች ከተሞች ለማይሎፋይብሮሲስ የሚደረጉ ጥናቶች
- Houston, TX19 ጥናቶች
- New York City, NY18 ጥናቶች
- Boston, MA12 ጥናቶች
- Durham, NC12 ጥናቶች
- Columbus, OH11 ጥናቶች
- Miami, FL10 ጥናቶች
- Salt Lake City, UT10 ጥናቶች
- Atlanta, GA9 ጥናቶች
- Tampa, FL9 ጥናቶች
- Nashville, TN9 ጥናቶች
- Cleveland, OH9 ጥናቶች
- Baldwin Park, CA9 ጥናቶች
በSeattle ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር53 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)49 ጥናቶች
- የፕሮስቴት ካንሰር42 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ40 ጥናቶች
- የጡንቻ ካንሰር39 ጥናቶች
- Metastatic Cancer39 ጥናቶች
- የኮሎሬክታል ካንሰር34 ጥናቶች
- የሳንባ ካንሰር33 ጥናቶች
- የእንቁላል ካንሰር30 ጥናቶች
- Multiple Myeloma22 ጥናቶች
- ማይሎዲስፕላስቲክ ሲንድሮሞች21 ጥናቶች
- አኩት ሊምፎብላስቲክ ሊውኬሚያ21 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።